RxDoctor Payments Data

Joshua Nichols, DPM

Podiatrist · Tallahassee, FLNPI 1790281475

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (33.2%), consulting fees and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Nvision Biomedical Technologies, Inc. at 56.2% of the total. Reporting peaked in 2022 at $11,084 and has fallen 87.5% since, to $1,380 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,129in general payments, 2019–2025

Across 130 payments — averaging $231.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nvision Biomedical Technologies, Inc.$17K
  • Arthrex$5K
  • CGG Medical Inc$5K
  • Vilex LLC$1K
  • Smith+Nephew$575
  • Stryker$383
  • plus $1K from 16 others

What the payments were for

  • Consulting fees$9,00030%
  • Travel & lodging$10,01633%
  • Food & beverage$5,11417%
  • Education$6,00020%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,129 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida

Medicare billing

Part B allowed, 2024
$298,846
Medicare patients
371
Services billed
1,839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl65$1,792
Gabapentin67$837
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen62$537
Cephalexin65$289
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$261
Pregabalin20$255
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim38$249
Allopurinol14$235
Methylprednisolone18$149
Meloxicam23$88

Paid to pharmacies, not to this prescriber.

Other podiatrist in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →